Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager

Vertex Pharmaceuticals Inc

NASDAQ:VRTX

Watchlist

Dividends

Price: 482.64 USD 1.18% Market Closed

Market Cap: 124.5B USD

Have any thoughts about
Vertex Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 482.64 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VRTX Alert

Vertex Pharmaceuticals Inc

482.64

+5.64 (+1.18%)

52 Week Range	343 505.78
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Vertex Pharmaceuticals Inc

What unique competitive advantages
does Vertex Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Vertex Pharmaceuticals Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Vertex Pharmaceuticals Inc.

What unique competitive advantages
does Vertex Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Vertex Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Vertex Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Vertex Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vertex Pharmaceuticals Inc.

Provide P/S
for Vertex Pharmaceuticals Inc.

Provide P/E
for Vertex Pharmaceuticals Inc.

Provide P/OCF
for Vertex Pharmaceuticals Inc.

Provide P/FCFE
for Vertex Pharmaceuticals Inc.

Provide P/B
for Vertex Pharmaceuticals Inc.

Provide EV/S
for Vertex Pharmaceuticals Inc.

Provide EV/GP
for Vertex Pharmaceuticals Inc.

Provide EV/EBITDA
for Vertex Pharmaceuticals Inc.

Provide EV/EBIT
for Vertex Pharmaceuticals Inc.

Provide EV/OCF
for Vertex Pharmaceuticals Inc.

Provide EV/FCFF
for Vertex Pharmaceuticals Inc.

Provide EV/IC
for Vertex Pharmaceuticals Inc.

Show me price targets
for Vertex Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Vertex Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Vertex Pharmaceuticals Inc?

What are the Net Income projections
for Vertex Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Vertex Pharmaceuticals Inc?

What are the EPS projections
for Vertex Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Vertex Pharmaceuticals Inc?

What are the EBIT projections
for Vertex Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Vertex Pharmaceuticals Inc?

Compare the revenue forecasts
for Vertex Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vertex Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vertex Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vertex Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Vertex Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Vertex Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Vertex Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Vertex Pharmaceuticals Inc.

Provide ROE
for Vertex Pharmaceuticals Inc.

Provide ROA
for Vertex Pharmaceuticals Inc.

Provide ROIC
for Vertex Pharmaceuticals Inc.

Provide ROCE
for Vertex Pharmaceuticals Inc.

Provide Gross Margin
for Vertex Pharmaceuticals Inc.

Provide Operating Margin
for Vertex Pharmaceuticals Inc.

Provide Net Margin
for Vertex Pharmaceuticals Inc.

Provide FCF Margin
for Vertex Pharmaceuticals Inc.

Show all solvency ratios
for Vertex Pharmaceuticals Inc.

Provide D/E Ratio
for Vertex Pharmaceuticals Inc.

Provide D/A Ratio
for Vertex Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Vertex Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Vertex Pharmaceuticals Inc.

Provide Quick Ratio
for Vertex Pharmaceuticals Inc.

Provide Current Ratio
for Vertex Pharmaceuticals Inc.

Provide Cash Ratio
for Vertex Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Vertex Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Vertex Pharmaceuticals Inc?

What is the current Free Cash Flow
of Vertex Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vertex Pharmaceuticals Inc.

VRTX

Income Statement

Net Income (Common)

Vertex Pharmaceuticals Inc
Net Income (Common)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Vertex Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Comparables:

ABBV

GILD

AMGN

ALNY

REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

	Net Income (Common)	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vertex Pharmaceuticals Inc NASDAQ:VRTX	Net Income (Common) -$489.9m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 0%
Abbvie Inc NYSE:ABBV	Net Income (Common) $5.3B	CAGR 3-Years -7%	CAGR 5-Years 5%	CAGR 10-Years 2%
Gilead Sciences Inc NASDAQ:GILD	Net Income (Common) $1.1B	CAGR 3-Years -41%	CAGR 5-Years -29%	CAGR 10-Years -18%
Amgen Inc NASDAQ:AMGN	Net Income (Common) $3.1B	CAGR 3-Years -18%	CAGR 5-Years -17%	CAGR 10-Years -5%
Alnylam Pharmaceuticals Inc NASDAQ:ALNY	Net Income (Common) -$72.9m	CAGR 3-Years 57%	CAGR 5-Years 39%	CAGR 10-Years 15%
Regeneron Pharmaceuticals Inc NASDAQ:REGN	Net Income (Common) $4.3B	CAGR 3-Years -11%	CAGR 5-Years 16%	CAGR 10-Years 27%

What is Vertex Pharmaceuticals Inc's Net Income (Common)?

Net Income (Common)
-489.9m USD

Based on the financial report for Jun 30, 2024, Vertex Pharmaceuticals Inc's Net Income (Common) amounts to -489.9m USD.

Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Vertex Pharmaceuticals Inc
Net Income (Common)

Vertex Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

See Also

What is Vertex Pharmaceuticals Inc's Net Income (Common)?

Net Income (Common)
-489.9m USD

What is Vertex Pharmaceuticals Inc's Net Income (Common) growth rate?

Net Income (Common) CAGR 10Y
0%

Company

Help

Tools

Stocks

Vertex Pharmaceuticals Inc NASDAQ:VRTX

Vertex Pharmaceuticals Inc Net Income (Common)

Vertex Pharmaceuticals Inc Net Income (Common) Peer Comparison

Competitive Net Income (Common) Analysis Latest Figures & CAGR of Competitors

See Also

What is Vertex Pharmaceuticals Inc's Net Income (Common)? Net Income (Common) -489.9m USD

What is Vertex Pharmaceuticals Inc's Net Income (Common) growth rate? Net Income (Common) CAGR 10Y 0%

Company

Help

Tools

Stocks

Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Vertex Pharmaceuticals Inc
Net Income (Common)

Vertex Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

What is Vertex Pharmaceuticals Inc's Net Income (Common)?

Net Income (Common)
-489.9m USD

What is Vertex Pharmaceuticals Inc's Net Income (Common) growth rate?

Net Income (Common) CAGR 10Y
0%